To analyze the rationale for performing penetrating keratoplasty (PK) rather than Descemet's stripping automated endothelial keratoplasty (DSAEK) in patients with bullous keratopathy (BK) in Japan.
INTRODUCTION
Recently, Descemet's stripping automated endothelial keratoplasty (DSAEK) has been widely adopted for the treatment of bullous keratopathy. [1] [2] [3] [4] [5] Most notably, DSAEK completely eliminates the requirement for central corneal incisions or sutures, thereby enabling the maintenance of much of the structural integrity of the cornea and inducing minimal refractive changes, refl ecting distinct advantages over standard penetrating kerato-plasty (PK). 6, 7 The avoidance of inherent risks associated with open-sky procedures is another great advantage of DSAEK. Most recently, Descemet's membrane endothelial keratoplasty (DMEK), a new type of endothelial keratoplasty in which only the Descemet's membrane with accompanying endothelial cell layer is transplanted, has been developed and has shown promise for rapid and improved postoperative visual function. 8 However, DSAEK/DMEK is not a panacea for the treatment of bullous keratopathy and PK appears to remain a vital surgical option for select patients with bullous keratopathy, even in the era of endothelial keratoplasty.
In this study, we analyzed recent corneal transplant cases in our hospital to analyze the rationale for performing PK rather than DSAEK in patients with bullous keratopathy in Japan.
PATIENTS AND METHODS
This study was approved by the Ethical Committee of Kanazawa University Graduate School of Medical Science and complied with the tenets of the Declaration of Helsinki. A total of 136 consecutive eyes of 130 patients with bullous keratopathy (49 men, 81 women; mean age: 72.0 ± 9.5 years, range: 45 to 92 years) treated by corneal transplantation at the Kanazawa University Hospital from August 2006 to July 2010 were enrolled in this retrospective case series. All eyes were initially considered to be suitable for DSAEK. However, PK was fi nally chosen for several patients after consideration of the conditions and inherent risk factors of the eye. Those patients were categorized as the "PK group" and the remaining patients treated by DSAEK were called the "DSAEK group." DSAEK procedures were performed as previously described. [9] [10] [11] In both groups, the number of patients and causes of bullous keratopathy were analyzed. In addition, specifi cally in the PK group, the reasons for not performing DSAEK were also analyzed.
We previously reported successful modifi cation of DSAEK without Descemet's membrane peeling for bullous keratopathy secondary to argon laser iridotomy; we termed the modifi ed procedure non-Descemet's stripping automated endothelial keratoplasty (nDSAEK). 9, 10 Although several patients enrolled in the current study were treated by nDSAEK, only the term DSAEK is used, regardless of preservation of host Descemet's membrane.
All data analysis was performed using SPSS software version 14.0 (SPSS, Inc., Chicago, IL). For all analyses, P values of less than .05 were considered to be statistically signifi cant. Table 1 summarizes the demographic data of the two groups. The DSAEK group included 83 eyes of 79 patients (23 men, 56 women; mean age: 72.5 ± 9.1 years, range: 45 to 88 years); the leading causes of bullous keratopathy in this group were secondary endothelial dysfunction after argon laser iridotomy (44.6%) and post-cataract surgery (16.9%). In contrast, the PK group included 53 eyes of 51 patients (26 men, 25 women; mean age: 71.1 ± 10.0 years, range: 47 to 92 years); the leading causes of bullous keratopathy in this group were post-cataract surgery (30.2%) and failed PK (30.2%). There were 9 (10.8%) patients with Fuchs dystrophy in the DSAEK group and 0 (0%) in the PK group. Statistical analysis indicated that the causes of bullous keratopathy differed signifi cantly between the two groups (P < .001, chi-square test). Preoperative mean best-corrected visual acuity was 20/250 in the DSAEK group and 20/1140 in the PK group; there was signifi cant difference between the two groups (P < .001, unpaired t test). At 6 to 12 months after surgery, mean best-corrected visual acuity improved to 20/36 (n = 80) in the DSAEK group and 20/160 (n = 47) in the PK group; there was signifi cant difference between the two groups (P < .001, unpaired t test).
RESULTS
Representative slit-lamp photographs of cases in the PK group are shown in Figure 1 . Reasons for contraindication to DSAEK were classifi ed into six categories: Table 2 summarizes the number of eyes that had one or more of these risk factors in the PK group. The most common risk factors for DSAEK included signifi cant stromal scarring (54.7%), iris abnormalities (43.4%), and lens abnormalities (30.2%). A total of 33 eyes (62.3%) had only one risk factor, whereas 20 eyes (37.7%) had multiple risk factors. Overall, 49 eyes (92.5%) had iris abnormality, lens abnormality, and/or signifi cant stromal scarring.
DISCUSSION
Compared with PK, DSAEK is performed through a relatively small incision that allows more rapid visual recovery, causes minimal change in astigmatism, and preserves the structural integrity of the eye. 7 Actually, postoperative mean best-corrected visual acuity in the DSAEK group was 20/36, which was better than that in the PK group (20/160) although indication and visual potential was different between the two groups. Previous studies have shown that early endothelial cell loss tends to be higher with DSAEK than with PK, 4, 6, 12 which raised concerns about long-term endothelial cell loss and graft survival. Price et al. showed that the 5-year graft survival rates for DSAEK were similar to those of PK in the multicenter Cornea Donor Study (95% vs 93% for Fuchs dystrophy and 76% vs 73% for pseudophakic or aphakic corneal edema). 13 Furthermore, the 5-year endothelial cell loss rate after DSAEK compared favorably with that measured after PK in the multicenter Cornea Donor Study (53% vs 70%). 13 Collectively, DSAEK has convincingly demonstrated the potential for better visual quality with favorable endothelial cell density compared to PK. 7, 13 Despite the superiority of DSAEK, PK remains a vital option for eyes with special circumstances. As shown in this study, 53 of 130 eyes (40.8%) required PK due to contraindications to DSAEK. Risk factors considered unsuitable for DSAEK include signifi cant stromal scarring (54.7%), iris abnormalities (eg, aniridia, irreversible mydriasis, large iridectomy, and large peripheral anterior synechia) (43.4%), and lens abnormalities (aphakia, post-IOL suture, and anterior chamber IOL with capsule defect) (30.2%). Overall, 33 eyes (62.3%) possessed only one risk factor and 20 eyes (37.7%) had multiple risk factors in the current series. In total, 49 of 53 (92.5%) eyes had one or more of these three risk factors. Severe stromal scarring may hinder postoperative visual acuity. Iris and lens abnormalities (iris-lens diaphragm injury) may cause air migration into the vitreous cavity and posterior chamber; this may cause serious intraoperative and postoperative complications, resulting in secondary glaucoma and/or donor dislocation.
14 For experienced DSAEK surgeons, these abnormalities of the host eye may not infl uence outcomes, and they may wish to perform DSAEK on these eyes; however, for DSAEK surgeons with average skill, careful preoperative evaluation of the host eye is of paramount importance for successful DSAEK. Of note, all DSAEK surgeries (n = 83) performed in this study were carefully selected, and all cases were successfully performed without serious complications.
Fuchs dystrophy and cataract surgery are the leading causes of bullous keratopathy in western countries. 15 In contrast, Fuchs dystrophy is extremely rare and cases of bullous keratopathy secondary to argon laser iridotomy are relatively common in Japan. [16] [17] [18] [19] In the current study, the leading causes of bullous keratopathy among all participants were argon laser iridotomy-bullous keratopathy (41 of 130, 31.5%) and post-cataract surgery (30 of 130, 23.1%). In contrast, the incidence of Fuchs dystrophy was relatively rare (9 of 130, 6.9%), which is consistent with previous reports. 19 The causes of bullous keratopathy differed to a statistically signifi cant degree between the DSAEK and PK groups (Table 1) . Argon laser iridotomy-bullous keratopathy was the leading cause of bullous keratopathy only in the DSAEK group (37 of 83, 44.6%), but not in the PK group (4 of 53, 7.5%). Usually, argon laser iridotomy-bullous keratopathy results in no stromal scarring in eyes with a normal iris and lens; such eyes are suitable for DSAEK. However, the tendency of argon laser iridotomy-bullous keratopathy to result in a shallow anterior chamber with a weak Zinn's zonule presents a challenge for performing DSAEK. 11 Previous cataract surgery was the second leading cause of bullous keratopathy in the DSAEK group (14 of 83, 16.9%) and the leading cause of bullous keratopathy in the PK group (16 of 53, 30.2%). These complicated eyes usually have a deformed iris with large iridectomy, and sometimes there is no lens (aphakia), no lens capsule, and no vitreous; the average surgeon may therefore wish to perform PK for these high-risk eyes. Previous trabeculectomy with tall bleb is also a risk factor for DSAEK because appropriate air tamponade pressure (approximately 25 to 30 mm Hg) during surgery is sometimes diffi cult to achieve due to air migration into the bleb. Furthermore, prior glaucoma surgery was a signifi cant risk factor for DSAEK graft failure; the 5-year graft survival rate was only 40% in eyes with prior glaucoma surgery. 13 Eyes with bullous keratopathy with anterior chamber IOL may be eligible for DSAEK 20 ; however, DSAEK was not indicated for such eyes in the current study (n = 4) because the rationale for using anterior chamber IOL in the referring hospital was to avoid IOL sutures, so these were usually complicated eyes without posterior capsules. In such cases, IOL removal and scleral fi xation of a posterior chamber IOL followed by DSAEK may be a viable option.
Another leading reason for choosing PK instead of DSAEK in the current study was failed PK (16 of 53, 30.2%). Until recently, the only surgical option for restoring failed penetrating graft clarity was to repeat the PK. Recently, DSAEK was proven to be an option for rehabilitation of failed PK. [21] [22] [23] [24] However, PK must still be performed in failed PK cases with preexisting high astigmatism and/or severe posterior host-stromal gap. This posterior gap is sometimes challenging for DSAEK graft attachment, and meticulous evaluation using slit-lamp biomicroscopy and anterior segment OCT is highly recommended. 21 For successful DSAEK, risk factors and contraindications should be carefully evaluated before surgery. PK appears to remain a vital surgical option for select patients with bullous keratopathy in Japan, even in the era of endothelial keratoplasty.
